Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001033475-25-000004·AVENIR CORP
Schedule 13G ownership disclosure
CYTOSORBENTS CORP
Common Stock, $0.001 par value per share · CUSIP: 23283X206
Event date: 2024-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- AVENIR CORP
Shares: 3,093,946.00 · Class: 5.7%
- Rooney James H
Shares: 3,093,946.00 · Class: 5.7%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001033475-25-000004
- Form type
- SCHEDULE 13G/A
- Filer
- AVENIR CORP
- CIK
- CIK 1033475
- Filed
- Feb 14, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership